Valuation: Center Laboratories, Inc.

Market Cap 28.37B 879M 768M 710M 652M 1.23B 84.69B 1.26B 8.47B 3.33B 41.36B 3.3B 3.23B 143B P/E 2024
-28.2x
P/E 2025 3.64x
Enterprise Value 32.41B 1B 878M 812M 745M 1.41B 96.76B 1.43B 9.68B 3.8B 47.25B 3.77B 3.69B 163B EV / Sales 2024
22.3x
EV / Sales 2025 23.1x
Free-Float
73.35%
Yield 2024
1.71%
Yield 2025 4.21%
1 day-0.13%
1 week-3.43%
Current month-0.39%
1 month+0.93%
3 months-8.54%
6 months-9.09%
Current year-8.65%
1 week 37.05
Extreme 37.05
38.95
1 month 36.8
Extreme 36.8
40.55
Current year 36.8
Extreme 36.8
51.4
1 year 33.1
Extreme 33.1
51.4
3 years 29.12
Extreme 29.1236
58.79
5 years 29.12
Extreme 29.1236
58.79
10 years 20.99
Extreme 20.9884
64.21
Manager TitleAgeSince
Chief Executive Officer - 03/08/1998
Director of Finance/CFO - 08/12/2022
Chief Tech/Sci/R&D Officer - 01/07/1983
Director TitleAgeSince
Chairman - 30/11/2022
Director/Board Member 61 14/06/2010
Director/Board Member - 14/06/2010
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-3.43%+7.47%-21.77% 882M
+1.42%-3.57%+48.58%+162.45% 1,031B
+1.14%-3.63%+51.54%+56.97% 595B
+3.40%+0.84%+32.23%+86.90% 431B
+0.42%-1.16%+29.43%+23.64% 326B
+1.03%-0.84%+29.58%+45.15% 277B
+0.49%-5.44%+21.00%+23.80% 263B
+1.59%+4.89%-22.56%-37.35% 224B
+3.13%+1.45%+23.37%+61.92% 193B
+2.63%-0.04%+22.70%+73.97% 164B
Average +1.46%-3.66%+24.34%+47.57% 350.52B
Weighted average by Cap. +1.58%-4.31%+34.57%+80.19%

Financials

2024 2025
Net sales 1.62B 50.12M 43.81M 40.52M 37.18M 70.37M 4.83B 71.59M 483M 190M 2.36B 188M 184M 8.14B 1.52B 46.97M 41.06M 37.97M 34.84M 65.95M 4.53B 67.09M 453M 178M 2.21B 176M 173M 7.63B
Net income -1.1B -34.19M -29.89M -27.64M -25.36M -48.01M -3.29B -48.84M -330M -129M -1.61B -128M -126M -5.56B 9.32B 289M 252M 233M 214M 406M 27.83B 413M 2.78B 1.09B 13.59B 1.08B 1.06B 46.92B
Net Debt 4.48B 139M 121M 112M 103M 195M 13.37B 198M 1.34B 526M 6.53B 521M 510M 22.55B 4.04B 125M 109M 101M 92.88M 176M 12.06B 179M 1.21B 474M 5.89B 470M 460M 20.34B
Logo Center Laboratories, Inc.
Center Laboratories Inc is a Taiwan-based company engaged in the development of pharmaceutical products. The Company's products mainly focus on internal liquids, including syrups, suspensions, liquids and other dosage forms. Pharmacological classifications include respiratory tract therapeutics such as cough suppressants, sputum expectorants, asthma medications, and runny nose relief, while antipyretic and analgesic medications and gastrointestinal medications are also in great demand, and a variety of internal liquids and lozenges for the treatment of central nervous system (CNS) such as epilepsy, dysphoria, dementia, and Parkinson's disease have already been introduced into the market. The Company is a specialized manufacturer of internal liquid.
Employees
-
Date Price Change Volume
16/07/26 NT$38.00 -0.13% 764,809
15/07/26 NT$38.05 +1.74% 1,232,606
14/07/26 NT$37.40 -1.71% 2,082,363
13/07/26 NT$38.05 -2.31% 2,309,344
09/07/26 NT$38.95 -1.02% 1,354,313
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. 4123 Stock